All In Biotech

Drug Trial Radar · NCT06428903

Comparative Bioavailability Study of Tablet and Granule Formulations of ADC189 and the Study of Ultra-high Dose

A Comparison Study of ADC189 Bioavailability Between Tablet and Granule in Healthy Chinese Adult Male Subjects, and the Safety and Pharmacokinetics of Ultra-high Dose ADC189

Last checked: Nov 19, 2026Latest source record: Jan 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

48

Actual

Start

Mar 12, 2024

Primary completion

Sep 22, 2024

Study completion Sep 22, 2024

Sponsor

Sponsor type
Industry
First posted
May 24, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Part 1 of this study will compare the pharmacokinetic performance of tablet and granule formulations of ADC189 under fasted conditions in healthy volunteers. A randomized, two-period, two-treatment crossover design is used. In each period, each volunteer will receive a single oral dose of the tablet or granule formulation without food. The purpose of Part 2 study is to determine the safety and pharmacokinetics of ultra high dose of ADC189 in healthy subjects.

Conditions

  • Healthy Volunteer

Interventions

  • ADC189 tabletDrug

    ADC189 tablet, 45 mg, single oral dose in each Group. (Part 1 study)

  • ADC189 granulesDrug

    ADC189 granules, 45 mg, single oral dose in each Group. (Part 1 study)

  • ADC189 180mgDrug

    ADC189 tablet, 180 mg, single oral dose. (Part 2 study)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ADC189 GranulesTime frame: 15 days
  2. ADC189 TabletTime frame: 15 days
  3. ADC189 Ultra high doseTime frame: 15 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Zhao Wei

    Jinan, Shang Dong, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.